Clinical Resources Core
临床资源核心
基本信息
- 批准号:10721316
- 负责人:
- 金额:$ 61.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAddressAdoptedAmerican IndiansAreaArthritisAutoimmunityBasic ScienceCOVID-19 pandemicCOVID-19 testingCOVID-19 therapeuticsCOVID-19 vaccineCardiovascular DiseasesCenters of Research ExcellenceCertificationCherokee IndianChild HealthChildhoodChronicClinicalClinical DataClinical InformaticsClinical InvestigatorClinical ResearchClinical TrialsClinical Trials Data Monitoring CommitteesClinical Trials NetworkCollaborationsCommunity OutreachContract ServicesContractsDataData AnalysesDatabasesDegenerative polyarthritisDevelopmentDiabetes MellitusDiseaseDisease OutcomeDissemination and ImplementationEffectivenessEnsureFeasibility StudiesFundingGrowthHealthHuman ResourcesHuman Subject ResearchIndividualInformaticsInfrastructureInpatientsInstitutionInstitutional Review BoardsInvestigationInvestmentsK-Series Research Career ProgramsLearningLife ExpectancyMalignant NeoplasmsMediationMedicalMentorsMinority GroupsNational Center for Advancing Translational SciencesNative American Research Center for HealthObesityOklahomaOutcomeParticipantPatient RecruitmentsPatientsPhasePlayPopulationProcessProtocols documentationRADx Underserved PopulationsRegistriesReproducibilityResearchResearch ActivityResearch PersonnelResearch Project GrantsResourcesRoleRuralRural MinoritySamplingScientistSiteSystemTherapeutic InterventionTranslational ResearchTribesUnderrepresented MinorityUnited States Indian Health ServiceUnited States National Institutes of HealthVariantViralWest VirginiaWorkbiobankcareerclinical infrastructurecohortcommunity engagementcommunity organizationscoronavirus diseasedata warehousehuman subjectimplementation researchimprovedinformatics infrastructureinnovationmemberminority communitiesminority health disparitynew growthpopulation healthprogramsrecruitrepositoryresearch facilityresponserural health disparitiessample collectionsatisfactiontherapeutic vaccinetranslational scientisttribal communityvaccine hesitancy
项目摘要
Although some improvement has been made since the Oklahoma Shared Clinical and Translational Resources
(OSCTR) initiation, Oklahoma remains consistently in or near the bottom 10% of states for the overall health of
its population. Oklahoma’s residents disproportionately suffer from chronic health problems, such as obesity,
diabetes, cardiovascular disease, and arthritis/autoimmunity. Oklahomans have a life expectancy of 4 years
shorter than the average US citizen, while American Indians have a life expectancy of more than 7 years
shorter than other groups within the US. With high percentages of rural (34%) and tribal (16%) populations,
Oklahoma has unique challenges and opportunities to implement clinical and translational research (CTR)
projects and dissemination and implementation research to improve health and disease outcomes. The Clinical
Resources (ClinRes) Core of the OSCTR has built a centralized system to support human subjects research
focused on these issues. The Core provides clinical research facilities and staff to assist with participant
recruitment and regulatory approvals, a CAP-certified Biorepository that has allowed the OSCTR to adopt or
establish registries, repositories, and cohorts to assist investigators in obtaining and utilizing high-quality
samples to support their research efforts, and infrastructure for accessing de-identified patient data to support
clinical research projects. These efforts have allowed the Core to support the careers of multiple CTR
investigators, including researchers who are members of the under-represented minority communities in the
state. The ClinRes Core will continue to provide this invaluable access to sample collections while supporting
the establishment and growth of new repositories focusing on the health issues of greatest concern to our
populations, including cancer, diabetes, and arthritis. The ClinRes core will continue to work with the
Community Engagement and Outreach (CEO) Core to build on the strong relationships developed with smaller
community organizations across the state during the COVID-19 pandemic. Together, these collaborations
enhance the overall opportunities of our CTR investigators to expand clinical study and trial access to residents
throughout the state to help increase participant diversity and address our rural and minority health disparities.
The ClinRes Core will continue to provide junior investigators with essential assistance with institutional IRB
applications, protocols, data safety monitoring boards, and other regulatory requirements and will work with the
Administrative Core to make access to resources and information more accessible to investigators, clinicians,
clinical research staff, and participants through the Gateway to Oklahoma portal. With the CEO Tribal
Engagement Unit, we will assist investigators in working with the Indian Health Service and tribal IRBs,
ensuring the protection of both individual human subjects and tribal community populations. Finally, we will
continue developing and supporting resources to grow our clinical research informatics capacity to facilitate
local and national research efforts.
尽管自俄克拉荷马州共享临床和翻译资源以来,
(OSCTR)启动,俄克拉荷马州仍然一贯在或接近底部10%的国家的整体健康
其人口。俄克拉荷马州的居民不成比例地患有肥胖等慢性健康问题,
糖尿病、心血管疾病和关节炎/自身免疫。俄克拉荷马人的预期寿命为4年
比美国公民的平均寿命短,而美国印第安人的预期寿命超过7年。
比美国其他国家都要短。农村人口(34%)和部落人口(16%)所占比例很高,
俄克拉荷马州有独特的挑战和机遇,实施临床和转化研究(CTR)
项目以及传播和实施研究,以改善健康和疾病结果。临床
OSCTR的核心已经建立了一个集中的系统来支持人类受试者的研究
专注于这些问题。核心提供临床研究设施和工作人员,以协助参与者
招募和监管批准,CAP认证的生物储存库,允许OSCTR采用或
建立登记处、资料库和队列,以协助研究者获得和利用高质量的
样本,以支持他们的研究工作,和基础设施,用于访问去识别的病人数据,以支持
临床研究项目。这些努力使核心能够支持多个CTR的职业生涯
调查人员,包括研究人员谁是代表不足的少数民族社区的成员,
状态ClinRes Core将继续提供对样本集的宝贵访问,同时支持
建立和发展新的知识库,重点关注我们最关心的健康问题,
包括癌症、糖尿病和关节炎。ClinRes核心将继续与
社区参与和外联(CEO)核心是建立在与较小的
在COVID-19大流行期间,全州的社区组织。这些合作
提高我们的CTR研究者的整体机会,以扩大临床研究和试验访问居民
在整个国家,以帮助增加参与者的多样性,并解决我们的农村和少数民族的健康差距。
ClinRes Core将继续为初级研究者提供机构IRB的基本协助
应用程序、协议、数据安全监控委员会和其他监管要求,并将与
管理核心,使资源和信息更容易获得研究者,临床医生,
临床研究人员和参与者通过网关到俄克拉荷马州门户网站。与CEO部落
参与单位,我们将协助调查人员与印度卫生服务和部落IRB,
确保保护人类个体和部落社区人口。最后我们将
继续开发和支持资源,以提高我们的临床研究信息学能力,
地方和国家的研究工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Hal Scofield其他文献
Autoantibodies identify primary Sjögren's syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B
自身抗体在缺乏针对 Ro/SS-A 和 La/SS-B 的血清 IgG 的患者中识别原发性干燥综合征
- DOI:
10.1136/ard-2022-223105 - 发表时间:
2023-09-01 - 期刊:
- 影响因子:20.600
- 作者:
Sherri Longobardi;Charmaine Lopez-Davis;Bhuwan Khatri;Constantin Georgescu;Cherilyn Pritchett-Frazee;Christina Lawrence;Astrid Rasmussen;Lida Radfar;Robert Hal Scofield;Alan N Baer;Susan A Robinson;Erika Darrah;Robert C Axtell;Gabriel Pardo;Jonathan D Wren;Kristi A Koelsch;Joel M Guthridge;Judith A James;Christopher J Lessard;Amy Darise Farris - 通讯作者:
Amy Darise Farris
Robert Hal Scofield的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Hal Scofield', 18)}}的其他基金
Autoimmunity in Post-Traumatic Stress Disorder
创伤后应激障碍中的自身免疫
- 批准号:
10427168 - 财政年份:2020
- 资助金额:
$ 61.68万 - 项目类别:
Autoimmunity in Post-Traumatic Stress Disorder
创伤后应激障碍中的自身免疫
- 批准号:
10704565 - 财政年份:2020
- 资助金额:
$ 61.68万 - 项目类别:
ShEEP Request for Peggy Sue by Bio-Techne
ShEEP 请求 Bio-Techne 提供 Peggy Sue
- 批准号:
9906453 - 财政年份:2019
- 资助金额:
$ 61.68万 - 项目类别:
Mitochondrial dysfunction, metabolic syndrome and oxidative damage in Sjogren's Syndrome
干燥综合征中的线粒体功能障碍、代谢综合征和氧化损伤
- 批准号:
9387723 - 财政年份:2017
- 资助金额:
$ 61.68万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 61.68万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 61.68万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 61.68万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 61.68万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 61.68万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 61.68万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 61.68万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 61.68万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 61.68万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 61.68万 - 项目类别:
Operating Grants














{{item.name}}会员




